Caplight Directory>Companies>General Prognostics-preview>Gpx


General Prognostics

General Prognostics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://gpx.ai

Last Round

Seed

Nov 12, 2024

Total Funding Raised

$3.25M

Momentum Score

25 /100

Company Overview

General Prognostics is a healthcare technology company that provides an AI-based platform for remote chronic disease management through bloodless blood tests.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMbloodless blood testsheart failure monitoringnon-invasive monitoringmedical AIpredictive health analyticsblood biomarker predictionwearable health techcardiovascular monitoringchronic disease managementdigital biomarkersmedtechclinician dashboardclinical trial support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

General Prognostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

General Prognostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 12, 2024
SeedSep 30, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Sean Matsuoka

Co-Founder COO

Founding Team

General Prognostics Investors

Notable investors and investment history

InvestorRounds
NEC XSeed
View all Investors

General Prognostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

General Prognostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about General Prognostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range4
Year Founded2020
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.